Skip to main content
. 2018 Oct 24;13(1):146–154. doi: 10.31616/asj.2018.0125

Table 3.

Results of the data analysis for length of stay, time from injury to surgery, drain removal time, radiographic parameters, postoperative blood loss, VAS scores and follow-up duration between the topical TXA and the control group

Variable Topical TXA group (n=29) Control group (n=28) p-value
Length of stay (day) 12.9±5.1 17.3±6.5 0.00a)
Time from injury to surgery (day) 5.2±3.6 6.8±3.5 0.09a)
Postoperative hospitalization (day) 7.7±2.7 10.4±6.2 0.03a)
Drain removal time (day) 2.8±0.9 3.2±0.8 0.04a)
Postoperative anterior body height loss (%) 17.3±10.6 15.5±12.7 0.57a)
Postoperative fracture body angle (°) 10.2±4.8 9.1±5.2 0.43a)
Postoperative blood loss (mL)
 Dressing gauze blood loss 32.2±26.9 43±28.1 0.14a)
 Drainage blood loss 246.7±125 445.7±211.1 0.00a)
 Total blood loss 279±135.2 488.8±223.5 0.00a)
VAS
 VAS at 24 hr before operation 5 (4–5) 5 (4–6) 0.52b)
 VAS at 24 hr after operation 7 (6.5–8) 7 (7–8) 0.80b)
 VAS at 48 hr after operation 6 (5–8) 5.5 (5–7) 0.23b)
 VAS at discharge from hospital 3 (2–5) 3.5 (3–5.8) 0.67b)
Follow-up duration (mo) 28.1±4.6 26.9±4.7 0.36b)

Values are presented as mean±standard deviation or median (interquartile range). Bold type is considered statistically significant (p <0.05).

VAS, Visual Analog Scale; TXA, tranexamic acid.

a)

Result of two sample t-test.

b)

Result of Mann–Whitney U-test.